73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Targeted therapy drug helps women with aggressive breast cancer live longer

Targeted therapy drug helps women with aggressive breast cancer live longer

by Denise Heady,University of California, Los AngelesSenior author Dr. Dennis Slamon says “there is absolutely no reason to wait” to give women treatment that combines ribociclib with hormone th

Targeted therapy drug helps women with aggressive breast cancer live longer

by Denise Heady,University of California, Los AngelesSenior author Dr. Dennis Slamon says “there is absolutely no reason to wait” to give women treatment that combines ribociclib with hormone th
Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy

Radiation therapy cuts low risk of recurrence in half for patients with 'good risk' breast cancer

by NRG OncologyA subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiationtherapy
Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according

Dementia complicates cancer care, increasing risk of poorer clinical outcome and patient experience

byRegenstrief InstituteCredit: Pixabay/CC0 Public DomainPre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according
Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc
Druggable targets found for treating rare, deadly nerve cancer MPNST

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S

Druggable targets found for treating rare, deadly nerve cancer MPNST

byCincinnati Children's Hospital Medical CenterTumor cell–state trajectories from NF to MPNST inferred by Slingshot. Arrows, transformation direction. Credit: Cincinnati Children's and S
Making glioblastoma more vulnerable to treatment

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o
RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking

RXR, the cell protein that keeps blood stem cells young and fit

RXR, the cell protein that keeps blood stem cells young and fitby Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Bone marrow histology in a normal mouse and in a mouse lacking
Immunotherapy Combo Boosts Survival in Metastatic Melanoma

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi
Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of

Targeting epiregulin in treatment-damaged tumor microenvironment restrains therapeutic resistance

by Liu Jia,Chinese Academy of SciencesGenotoxicity induces expression of EREG and other secreted factors of the SASP spectrum in human stromal cells.aTranscriptome-wide profiling of
RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac
SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)
  Key genetic code change drives common lung cancer type

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i